Britain’s regulator greenlights Novo Nordisk’s weight-loss pill on Thursday, needle-free win
Approval by Britain’s medicines regulator adds a new oral option and strengthens Novo Nordisk’s early lead versus Eli Lilly.
By Mohammed Al-Shehri·· 3 min
1 briefing · “needle-free”
Approval by Britain’s medicines regulator adds a new oral option and strengthens Novo Nordisk’s early lead versus Eli Lilly.